Risks and uncertainties include, among other things, the uncertainties inherent in research and development, including the ability to meet anticipated clinical endpoints, commencement and/or completion dates for clinical trials, regulatory submission dates, regulatory approval dates and/or launch dates, as well as the possibility of unfavorable new clinical data and further analyses of existing clinical data
Mild to moderate deficiencies of vitamin B12 are fairly common, with about 40% of people in Western populations reported to experience them [1]
6.3 Stem cell-derived EVs: redox-modulating nanotherapeutics Stem cell-derived EVs have emerged as functional nanotherapeutics capable of modulating redox balance, inflammation, and tissue repair in the context of ovarian aging (Geng et al., 2023
BPC-157 promotes angiogenesis: the formation of new blood vessels